Epigenetic reprogramming of cell cycle genes by ACK1 promotes breast cancer resistance to CDK4/6 inhibitor
Mithila Sawant(Washington University in St. Louis), Nupam P. Mahajan(Washington University in St. Louis)
Cited by 24
Related Papers
Ack1 Tyrosine Kinase Activation Correlates with Pancreatic Cancer Progression
|American Journal Of Pathology|2012|73
Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance
|Nature Communications|2022|57
Histone H2A Lys130 acetylation epigenetically regulates androgen production in prostate cancer
|Nature Communications|2023|40
SHP2 as a primordial epigenetic enzyme expunges histone H3 pTyr-54 to amend androgen receptor homeostasis
|Nature Communications|2024|8